Metastatic Melanoma

Showing NaN - NaN of 18

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Metastatic Melanoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Hodgkin Lymphoma Trial in

Active, not recruiting
  • Metastatic Melanoma
  • +22 more
  • Ipilimumab
  • +3 more
  • Birmingham, Alabama
  • +24 more
Jan 19, 2023

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Digestive System Carcinoma Trial in United

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +12 more
  • Tucson, Arizona
  • +60 more
Jan 11, 2023

Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Malignant Solid Tumor Trial in

Active, not recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +4 more
  • Phoenix, Arizona
  • +48 more
Jan 3, 2023

Melanoma, Advanced Melanoma, Metastatic Melanoma Trial in United States (CMP-001, Nivolumab)

Active, not recruiting
  • Melanoma
  • +3 more
  • Phoenix, Arizona
  • +24 more
Aug 1, 2022

Melanoma, Advanced Melanoma, Metastatic Melanoma Trial in United States (CMP-001, Nivolumab)

Active, not recruiting
  • Melanoma
  • +3 more
  • Phoenix, Arizona
  • +19 more
Aug 1, 2022

Metastatic Melanoma Trial in Lancaster, Philadelphia (Hypofractionated Radiation Therapy (HFRT), Nivolumab, Ipilimumab)

Recruiting
  • Metastatic Melanoma
  • Hypofractionated Radiation Therapy (HFRT)
  • +2 more
  • Lancaster, Pennsylvania
  • +1 more
Mar 30, 2022

Metastatic Melanoma Trial in United States (TLPLDC Vaccine)

Completed
  • Metastatic Melanoma
  • TLPLDC Vaccine
  • Birmingham, Alabama
  • +6 more
Sep 12, 2021

Metastatic Melanoma Trial in Worldwide (MORAb-004 (mAb))

Completed
  • Metastatic Melanoma
  • MORAb-004 (monoclonal antibody)
  • Scottsdale, Arizona
  • +28 more
Aug 6, 2021

Metastatic Melanoma Trial in Philadelphia (Ipilimumab, Stereotactic Body Radiation Therapy)

Completed
  • Metastatic Melanoma
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the Universirty of Pennsylvania
Jul 19, 2021

Metastatic Melanoma Trial in Duarte, Portland, Philadelphia (Bempegaldesleukin (NKTR-214), Nivolumab, 8?Zr-Df-IAB22M2C)

Withdrawn
  • Metastatic Melanoma
  • Bempegaldesleukin (NKTR-214)
  • +2 more
  • Duarte, California
  • +2 more
Jun 28, 2021

Metastatic Melanoma Trial in Worldwide (Lifileucel)

Active, not recruiting
  • Metastatic Melanoma
  • Lifileucel
  • La Jolla, California
  • +56 more
Mar 24, 2021

Metastatic Melanoma Trial in Switzerland, United States (RAF265)

Completed
  • Metastatic Melanoma
  • Aurora, Colorado
  • +10 more
Dec 11, 2020

Melanoma, Metastatic Melanoma, Solid Tumor Trial in United Kingdom, United States (MLN2480)

Completed
  • Melanoma
  • +3 more
  • San Francisco, California
  • +15 more
Jul 28, 2020

Imaging FDG Flare in Melanoma

Completed
  • Metastatic Melanoma
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Jul 7, 2020

Nausea and Vomiting In Patients Receiving Consecutive Days of

Terminated
  • Metastatic Melanoma
  • Nausea
    • Philadelphia, Pennsylvania
      Thomas Jefferson University Hospital
    Oct 19, 2016

    Metastatic Melanoma Trial in Philadelphia (Obatoclax Mesylate, Temozolomide)

    Terminated
    • Metastatic Melanoma
    • Philadelphia, Pennsylvania
      University of Pennsylvania
    Jul 20, 2016

    Metastatic Melanoma Trial in Philadelphia (131-I-MIP-1145)

    Terminated
    • Metastatic Melanoma
    • Philadelphia, Pennsylvania
      Hospital of the University of Pennsylvania
    Oct 7, 2011